Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 6 | Clinical Proteomics

Fig. 6

From: A rigorous evaluation of optimal peptide targets for MS-based clinical diagnostics of Coronavirus Disease 2019 (COVID-19)

Fig. 6

MS/MS spectra of SARS-CoV-2 peptides most confidently identified in PepQuery (p-value < 0.001) and across the most clinical samples. Spectral quality was interrogated using the Lorikeet viewer implemented within the Multi-Omics Visualization Platform (MVP); images for annotated PSMs for these peptides were created using the PDV platform from the Zhang lab [39]

Back to article page